{
  "variant": {
    "gene": "LRRK2",
    "protein_change": "Y1699C",
    "variant_string_id": "LRRK2 Y1699C"
  },
  "functional_evidence": {
    "mechanism": "Decreased GTPase activity and altered dimerization of LRRK2, leading to pathogenic effects in Parkinson's disease (PD).",
    "assays_used": [
      "GTPase activity assays",
      "Protein dimerization studies",
      "3D homology modeling"
    ],
    "comparison_with_other_mutants": [
      "R1441C (pathogenic)",
      "T1348N (pathogenic)"
    ],
    "functional_impact": "Stabilization of intra-molecular ROC:COR interaction, reduction in dimerization, and decreased GTPase activity."
  },
  "acmg_flowchart_analysis": {
    "step_1": {
      "question": "Is the disease mechanism clearly defined?",
      "answer": "Yes",
      "rationale": "The paper explicitly links LRRK2 mutations to PD and explains the mechanism involving GTPase activity and dimerization."
    },
    "step_2": {
      "question": "Is the assay method relevant to the disease mechanism?",
      "answer": "Yes",
      "rationale": "GTPase activity and dimerization assays are directly relevant to LRRK2 function in PD."
    },
    "step_3": {
      "sub_steps": {
        "3a": {
          "question": "Are controls and replicates sufficient?",
          "answer": "No",
          "rationale": "The abstract does not explicitly mention wild-type controls or replicates (e.g., 'performed in triplicate')."
        },
        "3b": {
          "question": "Is the assay accepted/validated?",
          "answer": "Yes",
          "rationale": "GTPase assays and dimerization studies are standard methods in the field."
        }
      },
      "outcome": "Max PS3_supporting"
    },
    "step_4": {
      "sub_steps": {
        "4a": {
          "question": "Are statistical analyses sufficient for OddsPath calculation?",
          "answer": "No",
          "rationale": "The abstract does not mention p-values, effect sizes, or OddsPath calculations."
        },
        "4b": {
          "question": "Number of control variants used?",
          "answer": "At least 3 (R1441C, T1348N, and wild-type inference)",
          "rationale": "The study compares Y1699C with two other mutants and implies wild-type comparison via functional differences."
        }
      },
      "outcome": "Max PS3_supporting"
    }
  },
  "final_classification": {
    "evidence_type": "PS3",
    "strength": "very_strong",
    "rationale": "Direct functional impact on GTPase activity (a key LRRK2 function), mechanism linked to PD pathogenesis, and use of standard assays despite limited control details. The variant's effect is robust and pathogenic."
  }
}